Skip to main content
OpenTrials

Clinical trial condition

Fragile X Syndrome

Explore clinical trials studying Fragile X Syndrome. Study availability and eligibility vary by location and protocol.

91 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Fragile X Syndrome trial results

Completed

A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome

NCT02126995

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • University of California Davis Pediatrics Sacramento, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • RUSH University Medical Center Chicago, Illinois, United States
View Trial Details
Completed

Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome

NCT01357239

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Novartis Investigative Site Sacramento, California, United States
  • Novartis Investigative Site Decatur, Georgia, United States
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Boston, Massachusetts, United States
View all 38 locations
View Trial Details
Completed

Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001

NCT00823368

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • University of California-Los Angeles Neuropsychiatric Institute Los Angeles, California, United States
  • M.I.N.D. Institute Sacramento, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Completed

Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome

NCT01325220

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • Miller Children's Hospital Long Beach, California, United States
  • University of California-Davis, M.I.N.D. Institute Sacramento, California, United States
  • Psychiatric Centers at San Diego San Diego, California, United States
View all 28 locations
View Trial Details
Completed

Biomarker and DNA Collection in Subjects Participating in Protocol 22003

NCT00892580

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • University of California-Los Angeles Neuropsychiatric Institute Los Angeles, California, United States
  • Yale Child Study Center New Haven, Connecticut, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
View Trial Details

Related conditions